Pfizer Declares Fourth-Quarter 2024 Dividend
Pfizer Inc. (NYSE: PFE) has announced that its board of directors has declared a $0.42 fourth-quarter 2024 dividend on the company's common stock. The dividend will be payable on December 2, 2024, to shareholders of record at the close of business on November 8, 2024. This marks Pfizer's 344th consecutive quarterly dividend, highlighting the company's commitment to returning value to shareholders.
Pfizer, a global biopharmaceutical company, focuses on developing innovative medicines and vaccines to improve people's lives. With a 175-year history, Pfizer strives to set industry standards in quality, safety, and value in healthcare product development. The company collaborates with various stakeholders to expand access to affordable healthcare worldwide.
Pfizer Inc. (NYSE: PFE) ha annunciato che il suo consiglio di amministrazione ha dichiarato un dividendo di $0,42 per il quarto trimestre del 2024 sulle azioni ordinarie dell'azienda. Il dividendo sarà pagabile il 2 dicembre 2024, agli azionisti registrati alla chiusura degli affari dell'8 novembre 2024. Questo segna il 344° dividendo trimestrale consecutivo di Pfizer, evidenziando l'impegno dell'azienda a restituire valore agli azionisti.
Pfizer, una compagnia biofarmaceutica globale, si concentra nello sviluppo di medicinali e vaccini innovativi per migliorare la vita delle persone. Con una storia di 175 anni, Pfizer si sforza di stabilire standard nel settore in termini di qualità, sicurezza e valore nello sviluppo di prodotti sanitari. L'azienda collabora con vari portatori d'interesse per espandere l'accesso a una sanità accessibile in tutto il mondo.
Pfizer Inc. (NYSE: PFE) ha anunciado que su junta directiva ha declarado un dividendo de $0.42 para el cuarto trimestre de 2024 sobre las acciones ordinarias de la compañía. El dividendo será pagadero el 2 de diciembre de 2024 a los accionistas registrados al cierre de operaciones del 8 de noviembre de 2024. Esto marca el 344° dividendo trimestral consecutivo de Pfizer, destacando el compromiso de la compañía de devolver valor a los accionistas.
Pfizer, una empresa biofarmacéutica global, se enfoca en desarrollar medicamentos y vacunas innovadoras para mejorar la vida de las personas. Con una historia de 175 años, Pfizer se esfuerza por establecer estándares en la industria en calidad, seguridad y valor en el desarrollo de productos de atención médica. La compañía colabora con varios interesados para expandir el acceso a atención médica asequible en todo el mundo.
파이저 주식회사 (NYSE: PFE)는 이사회가 회사 보통주에 대해 2024년 4분기 배당금 $0.42를 선언했다고 발표했습니다. 이 배당금은 2024년 12월 2일에 지급될 예정이며, 2024년 11월 8일 업무 종료 시 기준으로 등록된 주주에게 지급됩니다. 이는 파이저의 344번째 연속 분기 배당금으로, 주주들에게 가치를 환원하려는 회사의 노력을 강조합니다.
글로벌 생명공학 제약 회사인 파이저는 사람들의 삶을 개선하기 위해 혁신적인 의약품과 백신을 개발하는 데 주력하고 있습니다. 175년의 역사를 가진 파이저는 의료 제품 개발에서 품질, 안전성 및 가치를 업계 기준으로 설정하기 위해 노력하고 있습니다. 이 회사는 세계적으로 저렴한 의료 접근성을 확장하기 위해 다양한 이해관계자와 협력하고 있습니다.
Pfizer Inc. (NYSE: PFE) a annoncé que son conseil d'administration a déclaré un dividende de 0,42 $ pour le quatrième trimestre de 2024 sur les actions ordinaires de la société. Le dividende sera versé le 2 décembre 2024 aux actionnaires enregistrés à la clôture des affaires le 8 novembre 2024. Cela marque le 344e dividende trimestriel consécutif de Pfizer, soulignant l'engagement de l'entreprise à redonner de la valeur aux actionnaires.
Pfizer, une entreprise biopharmaceutique mondiale, se concentre sur le développement de médicaments et de vaccins innovants pour améliorer la vie des gens. Forte de 175 ans d'histoire, Pfizer s'efforce de fixer des normes industrielles en matière de qualité, de sécurité et de valeur dans le développement de produits de santé. L'entreprise collabore avec divers partenaires intéressés pour élargir l'accès à des soins de santé abordables dans le monde entier.
Pfizer Inc. (NYSE: PFE) hat bekannt gegeben, dass der Vorstand eine Dividende in Höhe von $0,42 für das vierte Quartal 2024 auf die Stammaktien des Unternehmens erklärt hat. Die Dividende wird am 2. Dezember 2024 an die Aktionäre ausgezahlt, die zum Ende des Geschäftstags am 8. November 2024 im Aktienregister stehen. Dies ist die 344. aufeinanderfolgende vierteljährliche Dividende von Pfizer, was das Engagement des Unternehmens hervorhebt, den Aktionären Wert zurückzugeben.
Pfizer, ein globales biopharmazeutisches Unternehmen, konzentriert sich auf die Entwicklung innovativer Medikamente und Impfstoffe zur Verbesserung des Lebens der Menschen. Mit einer 175-jährigen Geschichte strebt Pfizer danach, in der Qualität, Sicherheit und im Wert der Entwicklung von Gesundheitsprodukten Branchenstandards zu setzen. Das Unternehmen arbeitet mit verschiedenen Interessengruppen zusammen, um den Zugang zu erschwinglicher Gesundheitsversorgung weltweit zu erweitern.
- Consistent dividend payments, with the 344th consecutive quarterly dividend declared
- Maintained dividend amount at $0.42 per share, indicating financial stability
- None.
Board of Directors approves quarterly cash dividend of
About Pfizer: Breakthroughs That Change Patients’ Lives
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on X at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Category: Finance
View source version on businesswire.com: https://www.businesswire.com/news/home/20241008457849/en/
Media Contact:
PfizerMediaRelations@Pfizer.com
+1 (212) 733-1226
Investor Contact:
IR@Pfizer.com
+1 (212) 733-4848
Source: Pfizer Inc.
FAQ
What is the amount of Pfizer's (PFE) fourth-quarter 2024 dividend?
When will Pfizer (PFE) pay its fourth-quarter 2024 dividend?
How many consecutive quarterly dividends has Pfizer (PFE) paid?
What is the record date for Pfizer's (PFE) fourth-quarter 2024 dividend?
